

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.64050506 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.64050506 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.64050506 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.64050506 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.64050506 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.64050506 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.15803938 |
| 8 | B cell receptor signaling pathway (GO:0050853) | 5.56873469 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.52011443 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.47720317 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.39342898 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.09570635 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.09570635 |
| 14 | detection of other organism (GO:0098543) | 5.06518044 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.96838658 |
| 16 | detection of bacterium (GO:0016045) | 4.92462712 |
| 17 | * regulation of interferon-beta biosynthetic process (GO:0045357) | 4.91274072 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 4.69425544 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.67369383 |
| 20 | positive regulation of antigen processing and presentation (GO:0002579) | 4.43063007 |
| 21 | microglial cell activation (GO:0001774) | 4.41687002 |
| 22 | regulation of B cell differentiation (GO:0045577) | 4.40096468 |
| 23 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.37106006 |
| 24 | detection of external biotic stimulus (GO:0098581) | 4.34519982 |
| 25 | response to interleukin-15 (GO:0070672) | 4.34433505 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.29338430 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.22795276 |
| 28 | response to host immune response (GO:0052572) | 4.22795276 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 4.15750007 |
| 30 | mature B cell differentiation (GO:0002335) | 4.15392051 |
| 31 | * positive regulation of interferon-alpha production (GO:0032727) | 4.15115855 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.03266922 |
| 33 | response to host (GO:0075136) | 4.03266922 |
| 34 | response to host defenses (GO:0052200) | 4.03266922 |
| 35 | cellular response to interleukin-15 (GO:0071350) | 3.99133306 |
| 36 | * regulation of interferon-alpha production (GO:0032647) | 3.97623413 |
| 37 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.84393902 |
| 38 | negative regulation of granulocyte differentiation (GO:0030853) | 3.79003924 |
| 39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.76674922 |
| 40 | respiratory burst (GO:0045730) | 3.76076961 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.75682375 |
| 42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.75022507 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74886141 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.74326641 |
| 45 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.72940009 |
| 46 | regulation of antigen processing and presentation (GO:0002577) | 3.72522514 |
| 47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.70115418 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.69066775 |
| 49 | tolerance induction (GO:0002507) | 3.67783034 |
| 50 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.64613145 |
| 51 | neutrophil mediated immunity (GO:0002446) | 3.63031059 |
| 52 | neutrophil activation (GO:0042119) | 3.62963857 |
| 53 | macrophage activation (GO:0042116) | 3.61818330 |
| 54 | negative regulation of B cell proliferation (GO:0030889) | 3.57130242 |
| 55 | * positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56949598 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.54838214 |
| 57 | germinal center formation (GO:0002467) | 3.52020454 |
| 58 | negative regulation of T cell mediated immunity (GO:0002710) | 3.49109414 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 3.48410277 |
| 60 | response to peptidoglycan (GO:0032494) | 3.47093032 |
| 61 | NIK/NF-kappaB signaling (GO:0038061) | 3.43430237 |
| 62 | granulocyte activation (GO:0036230) | 3.43362327 |
| 63 | B cell homeostasis (GO:0001782) | 3.41278117 |
| 64 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.40606190 |
| 65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38345865 |
| 66 | negative regulation of cell killing (GO:0031342) | 3.38345865 |
| 67 | negative thymic T cell selection (GO:0045060) | 3.37032337 |
| 68 | positive thymic T cell selection (GO:0045059) | 3.35693153 |
| 69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34949176 |
| 70 | defense response to protozoan (GO:0042832) | 3.34775819 |
| 71 | B cell proliferation (GO:0042100) | 3.34416897 |
| 72 | myeloid dendritic cell activation (GO:0001773) | 3.32797209 |
| 73 | negative regulation of phagocytosis (GO:0050765) | 3.31548302 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.31369899 |
| 75 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.31369899 |
| 76 | B cell mediated immunity (GO:0019724) | 3.30897568 |
| 77 | myeloid cell activation involved in immune response (GO:0002275) | 3.28508225 |
| 78 | cellular extravasation (GO:0045123) | 3.28488730 |
| 79 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28233945 |
| 80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27578184 |
| 81 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.26847126 |
| 82 | negative T cell selection (GO:0043383) | 3.25351684 |
| 83 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.25123730 |
| 84 | response to type I interferon (GO:0034340) | 3.24244648 |
| 85 | cellular response to zinc ion (GO:0071294) | 3.23772200 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21727969 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 3.18904203 |
| 88 | type I interferon signaling pathway (GO:0060337) | 3.18897359 |
| 89 | cellular response to type I interferon (GO:0071357) | 3.18897359 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 3.17088198 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 3.16976782 |
| 92 | regulation of B cell proliferation (GO:0030888) | 3.15373401 |
| 93 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.13029835 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 3.12063491 |
| 95 | negative regulation of type 2 immune response (GO:0002829) | 3.11277747 |
| 96 | leukocyte degranulation (GO:0043299) | 3.11239702 |
| 97 | leukocyte aggregation (GO:0070486) | 3.10922327 |
| 98 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.09459148 |
| 99 | T cell selection (GO:0045058) | 3.07247251 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06598503 |
| 101 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06571072 |
| 102 | positive T cell selection (GO:0043368) | 3.06550056 |
| 103 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.05130400 |
| 104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.04674544 |
| 105 | myeloid leukocyte mediated immunity (GO:0002444) | 3.04080597 |
| 106 | negative regulation of bone resorption (GO:0045779) | 3.01994256 |
| 107 | mature B cell differentiation involved in immune response (GO:0002313) | 3.01912735 |
| 108 | thymic T cell selection (GO:0045061) | 3.01348265 |
| 109 | * positive regulation of interferon-beta production (GO:0032728) | 3.00447633 |
| 110 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99272782 |
| 111 | * positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.98400604 |
| 112 | response to protozoan (GO:0001562) | 2.96035626 |
| 113 | regulation of tolerance induction (GO:0002643) | 2.95525977 |
| 114 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.93980081 |
| 115 | positive regulation of mast cell degranulation (GO:0043306) | 2.93377424 |
| 116 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.93377424 |
| 117 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.91753367 |
| 118 | T cell homeostasis (GO:0043029) | 2.91634579 |
| 119 | response to laminar fluid shear stress (GO:0034616) | 2.90626098 |
| 120 | T cell migration (GO:0072678) | 2.89998674 |
| 121 | positive regulation of histone deacetylation (GO:0031065) | 2.86286448 |
| 122 | dendritic cell differentiation (GO:0097028) | 2.85924580 |
| 123 | regulation of superoxide anion generation (GO:0032928) | 2.85007737 |
| 124 | myeloid leukocyte activation (GO:0002274) | 2.83787576 |
| 125 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.82105627 |
| 126 | lymphocyte homeostasis (GO:0002260) | 2.81585493 |
| 127 | regulation of mast cell activation (GO:0033003) | 2.81066906 |
| 128 | cellular response to exogenous dsRNA (GO:0071360) | 2.80462261 |
| 129 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.79322252 |
| 130 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.79075467 |
| 131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.78728596 |
| 132 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76410004 |
| 133 | positive regulation of B cell activation (GO:0050871) | 2.76385813 |
| 134 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.76055426 |
| 135 | positive regulation of B cell proliferation (GO:0030890) | 2.74616843 |
| 136 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.73439823 |
| 137 | regulation of B cell apoptotic process (GO:0002902) | 2.71674961 |
| 138 | positive regulation of mast cell activation (GO:0033005) | 2.70991785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.45323002 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.30718541 |
| 3 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.22539176 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.09580479 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.83998706 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.80410778 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.68398821 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.59510493 |
| 9 | * MYC_22102868_ChIP-Seq_BL_Human | 3.43547023 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.40448059 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.20701697 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20402598 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.15567666 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.03503190 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.90852081 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65299887 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54322954 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54037389 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.51927712 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51694446 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.47929612 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.43828152 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43712840 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.42508788 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.42473429 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.38572002 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35838479 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.26088559 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.24648672 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 2.23165273 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20650895 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.10701546 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09092854 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08683889 |
| 35 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.08583876 |
| 36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.06058799 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.03231429 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.97270221 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90561070 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.89079026 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86960329 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82964191 |
| 43 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.75225029 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69582354 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63920748 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62972965 |
| 47 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60716258 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58082288 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54141619 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54069848 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51551190 |
| 52 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50980835 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50961797 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48513992 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.45437092 |
| 56 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39727874 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35893195 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33180501 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32590543 |
| 60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26581180 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26464770 |
| 62 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.23630928 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22252759 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21814844 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18678956 |
| 66 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.18221046 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15001960 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12863410 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09792299 |
| 70 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08388800 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08129360 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07755443 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07616833 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06144508 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04168852 |
| 76 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03370854 |
| 77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02372932 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01400352 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99044105 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98381965 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96693503 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95130957 |
| 83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95090095 |
| 84 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94554276 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94379664 |
| 86 | * P68_20966046_ChIP-Seq_HELA_Human | 0.93926220 |
| 87 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93396953 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91991869 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.91830187 |
| 90 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91165623 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89770621 |
| 92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88997720 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88343835 |
| 94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87954838 |
| 95 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87410763 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87165078 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86688335 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85847820 |
| 99 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85795135 |
| 100 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.84828675 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84333020 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83998077 |
| 103 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80109484 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79892767 |
| 105 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78490854 |
| 106 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78392889 |
| 107 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75259561 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73591183 |
| 109 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.71956137 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71675316 |
| 111 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.70995085 |
| 112 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.70639738 |
| 113 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.68409560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.05683177 |
| 2 | MP0003303_peritoneal_inflammation | 4.27076398 |
| 3 | MP0001800_abnormal_humoral_immune | 3.83770099 |
| 4 | * MP0001790_abnormal_immune_system | 3.77042293 |
| 5 | * MP0005387_immune_system_phenotype | 3.77042293 |
| 6 | MP0000685_abnormal_immune_system | 3.37374632 |
| 7 | * MP0002452_abnormal_antigen_presenting | 3.25143681 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.20064371 |
| 9 | MP0004510_myositis | 3.03541354 |
| 10 | MP0005671_abnormal_response_to | 3.03204070 |
| 11 | * MP0002723_abnormal_immune_serum | 2.85435824 |
| 12 | MP0003436_decreased_susceptibility_to | 2.73395970 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.65255546 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.63501458 |
| 15 | * MP0002419_abnormal_innate_immunity | 2.63481682 |
| 16 | * MP0001819_abnormal_immune_cell | 2.62769289 |
| 17 | MP0006082_CNS_inflammation | 2.53954103 |
| 18 | * MP0005025_abnormal_response_to | 2.36051203 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.27555922 |
| 20 | * MP0002398_abnormal_bone_marrow | 2.22421251 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.21036801 |
| 22 | MP0009785_altered_susceptibility_to | 2.18706937 |
| 23 | * MP0000716_abnormal_immune_system | 2.17693740 |
| 24 | MP0000689_abnormal_spleen_morphology | 2.04357085 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.02832584 |
| 26 | MP0002405_respiratory_system_inflammati | 1.95395234 |
| 27 | MP0001873_stomach_inflammation | 1.91951178 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.91780944 |
| 29 | MP0005310_abnormal_salivary_gland | 1.91730524 |
| 30 | MP0002132_abnormal_respiratory_system | 1.90042783 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.88498006 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.85119033 |
| 33 | * MP0001845_abnormal_inflammatory_respons | 1.79802468 |
| 34 | MP0002722_abnormal_immune_system | 1.76214736 |
| 35 | * MP0002429_abnormal_blood_cell | 1.75297069 |
| 36 | MP0008260_abnormal_autophagy | 1.74857272 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.74047333 |
| 38 | MP0001853_heart_inflammation | 1.73985583 |
| 39 | MP0004947_skin_inflammation | 1.72551318 |
| 40 | MP0004381_abnormal_hair_follicle | 1.62929433 |
| 41 | MP0009278_abnormal_bone_marrow | 1.57857509 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.54258691 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.53313802 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.53050409 |
| 45 | MP0009840_abnormal_foam_cell | 1.51325825 |
| 46 | * MP0010155_abnormal_intestine_physiology | 1.44472652 |
| 47 | MP0003763_abnormal_thymus_physiology | 1.41213581 |
| 48 | MP0008469_abnormal_protein_level | 1.39726493 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.37966963 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.37171373 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.30765451 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.26361601 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.25458112 |
| 54 | MP0003724_increased_susceptibility_to | 1.24843008 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.23534132 |
| 56 | MP0003045_fibrosis | 1.22502191 |
| 57 | MP0002006_tumorigenesis | 1.21345398 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.16226974 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.14774523 |
| 60 | MP0002254_reproductive_system_inflammat | 1.13157393 |
| 61 | MP0003091_abnormal_cell_migration | 1.10466552 |
| 62 | MP0001851_eye_inflammation | 1.09794477 |
| 63 | MP0002933_joint_inflammation | 1.09117270 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.07559272 |
| 65 | MP0003075_altered_response_to | 1.06888967 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.03449901 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.03449901 |
| 68 | MP0003448_altered_tumor_morphology | 1.03433497 |
| 69 | MP0003690_abnormal_glial_cell | 1.03360624 |
| 70 | MP0000343_altered_response_to | 1.02887537 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.02489618 |
| 72 | MP0008961_abnormal_basal_metabolism | 1.01676417 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 1.01047390 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.00664177 |
| 75 | MP0000604_amyloidosis | 0.97321827 |
| 76 | MP0003866_abnormal_defecation | 0.97238625 |
| 77 | MP0005166_decreased_susceptibility_to | 0.95347034 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.93148252 |
| 79 | MP0002928_abnormal_bile_duct | 0.93058188 |
| 80 | MP0003828_pulmonary_edema | 0.87720864 |
| 81 | MP0010307_abnormal_tumor_latency | 0.87564810 |
| 82 | MP0008004_abnormal_stomach_pH | 0.86950618 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.85781806 |
| 84 | MP0000249_abnormal_blood_vessel | 0.81032973 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.80265792 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.79747634 |
| 87 | MP0009764_decreased_sensitivity_to | 0.76562583 |
| 88 | MP0005164_abnormal_response_to | 0.72823485 |
| 89 | MP0005023_abnormal_wound_healing | 0.72278881 |
| 90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70824181 |
| 91 | MP0000490_abnormal_crypts_of | 0.68769724 |
| 92 | MP0001663_abnormal_digestive_system | 0.68375981 |
| 93 | MP0005390_skeleton_phenotype | 0.65315953 |
| 94 | MP0000609_abnormal_liver_physiology | 0.59664239 |
| 95 | MP0000858_altered_metastatic_potential | 0.59317738 |
| 96 | MP0002009_preneoplasia | 0.58896552 |
| 97 | MP0004130_abnormal_muscle_cell | 0.57620480 |
| 98 | MP0005670_abnormal_white_adipose | 0.57147931 |
| 99 | MP0009763_increased_sensitivity_to | 0.56714860 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.56449102 |
| 101 | MP0002332_abnormal_exercise_endurance | 0.55700055 |
| 102 | MP0001915_intracranial_hemorrhage | 0.55099676 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.54525718 |
| 104 | MP0004883_abnormal_blood_vessel | 0.54221180 |
| 105 | MP0008874_decreased_physiological_sensi | 0.54015825 |
| 106 | MP0005451_abnormal_body_composition | 0.53347489 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.52700986 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.52479146 |
| 109 | MP0004185_abnormal_adipocyte_glucose | 0.52212651 |
| 110 | MP0003795_abnormal_bone_structure | 0.51102528 |
| 111 | MP0005621_abnormal_cell_physiology | 0.50011637 |
| 112 | MP0002168_other_aberrant_phenotype | 0.49969221 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.49514666 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.49131648 |
| 115 | MP0000371_diluted_coat_color | 0.48674821 |
| 116 | MP0008873_increased_physiological_sensi | 0.48156246 |
| 117 | MP0003878_abnormal_ear_physiology | 0.44321776 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.44321776 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.44219212 |
| 120 | MP0000313_abnormal_cell_death | 0.42046213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.69294294 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.54367800 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.39449500 |
| 4 | Colitis (HP:0002583) | 5.22271718 |
| 5 | Cellulitis (HP:0100658) | 4.82083295 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.69289993 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 4.61591265 |
| 8 | Inflammation of the large intestine (HP:0002037) | 4.58355593 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.48406640 |
| 10 | Gastrointestinal inflammation (HP:0004386) | 4.36902985 |
| 11 | Recurrent viral infections (HP:0004429) | 4.36398041 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.10130715 |
| 13 | Hypochromic microcytic anemia (HP:0004840) | 4.08122129 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.97898935 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.97449975 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.88273839 |
| 17 | Chronic otitis media (HP:0000389) | 3.87653273 |
| 18 | Recurrent skin infections (HP:0001581) | 3.83953122 |
| 19 | IgM deficiency (HP:0002850) | 3.80533433 |
| 20 | Meningitis (HP:0001287) | 3.74836052 |
| 21 | Vasculitis (HP:0002633) | 3.69679885 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.61802202 |
| 23 | Hypochromic anemia (HP:0001931) | 3.55973303 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.54340685 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.51924844 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.51924844 |
| 27 | Verrucae (HP:0200043) | 3.47969244 |
| 28 | Papilloma (HP:0012740) | 3.47969244 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46251221 |
| 30 | Glomerulonephritis (HP:0000099) | 3.45562005 |
| 31 | Emphysema (HP:0002097) | 3.44201903 |
| 32 | Hematochezia (HP:0002573) | 3.34001747 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 3.33542399 |
| 34 | Recurrent sinusitis (HP:0011108) | 3.33361326 |
| 35 | Prolonged bleeding time (HP:0003010) | 3.27186365 |
| 36 | Keratoconjunctivitis (HP:0001096) | 3.26715093 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 3.21975800 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.19817265 |
| 39 | Osteomyelitis (HP:0002754) | 3.16152495 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 3.14124374 |
| 41 | Lymphopenia (HP:0001888) | 3.13965683 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.13469274 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.13469274 |
| 44 | Abnormality of glycolipid metabolism (HP:0010969) | 3.13469274 |
| 45 | Myositis (HP:0100614) | 3.11547078 |
| 46 | Spontaneous hematomas (HP:0007420) | 3.08256823 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02172858 |
| 48 | Obstructive lung disease (HP:0006536) | 3.02172858 |
| 49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.98449107 |
| 50 | Chronic sinusitis (HP:0011109) | 2.92229968 |
| 51 | Recurrent pneumonia (HP:0006532) | 2.88582871 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.88561074 |
| 53 | Episodic fever (HP:0001954) | 2.87148845 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.83302598 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.82157184 |
| 56 | Recurrent lower respiratory tract infections (HP:0002783) | 2.81555778 |
| 57 | Hemoptysis (HP:0002105) | 2.80597317 |
| 58 | Pustule (HP:0200039) | 2.78088110 |
| 59 | Restrictive lung disease (HP:0002091) | 2.74082302 |
| 60 | Nasal polyposis (HP:0100582) | 2.70346416 |
| 61 | Gingival bleeding (HP:0000225) | 2.66339045 |
| 62 | T lymphocytopenia (HP:0005403) | 2.64905017 |
| 63 | Abnormality of the fingertips (HP:0001211) | 2.60305836 |
| 64 | Periodontitis (HP:0000704) | 2.59818729 |
| 65 | Epistaxis (HP:0000421) | 2.59508689 |
| 66 | Increased IgE level (HP:0003212) | 2.59197070 |
| 67 | Orchitis (HP:0100796) | 2.57640282 |
| 68 | Increased IgM level (HP:0003496) | 2.56864610 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.56202394 |
| 70 | Abnormality of the peritoneum (HP:0002585) | 2.55534589 |
| 71 | Gingivitis (HP:0000230) | 2.55165763 |
| 72 | Abnormality of T cell number (HP:0011839) | 2.53754054 |
| 73 | Granulocytopenia (HP:0001913) | 2.52566500 |
| 74 | Anorexia (HP:0002039) | 2.52326907 |
| 75 | Chronic diarrhea (HP:0002028) | 2.51263741 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50249630 |
| 77 | Pulmonary embolism (HP:0002204) | 2.50160902 |
| 78 | Mitral stenosis (HP:0001718) | 2.47606025 |
| 79 | Leukocytosis (HP:0001974) | 2.45330940 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.44771308 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.44335694 |
| 82 | Microcytic anemia (HP:0001935) | 2.42734829 |
| 83 | Complement deficiency (HP:0004431) | 2.41972124 |
| 84 | Optic neuritis (HP:0100653) | 2.40813427 |
| 85 | Retrobulbar optic neuritis (HP:0100654) | 2.40813427 |
| 86 | Sepsis (HP:0100806) | 2.40728822 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.37423490 |
| 88 | Cerebral aneurysm (HP:0004944) | 2.36762230 |
| 89 | Myocardial infarction (HP:0001658) | 2.36707564 |
| 90 | Petechiae (HP:0000967) | 2.34738612 |
| 91 | IgA deficiency (HP:0002720) | 2.33988089 |
| 92 | Thyroiditis (HP:0100646) | 2.28830830 |
| 93 | Peritonitis (HP:0002586) | 2.27750806 |
| 94 | Loss of speech (HP:0002371) | 2.26530123 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 2.24180577 |
| 96 | Disinhibition (HP:0000734) | 2.24045760 |
| 97 | Fatigue (HP:0012378) | 2.22455646 |
| 98 | Arterial thrombosis (HP:0004420) | 2.21266815 |
| 99 | Stomatitis (HP:0010280) | 2.19739519 |
| 100 | Mucopolysacchariduria (HP:0008155) | 2.18622728 |
| 101 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18622728 |
| 102 | Encephalitis (HP:0002383) | 2.17534422 |
| 103 | Skin rash (HP:0000988) | 2.16113650 |
| 104 | Skin ulcer (HP:0200042) | 2.14708140 |
| 105 | Abnormality of the endocardium (HP:0004306) | 2.13579544 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 2.13218416 |
| 107 | Gangrene (HP:0100758) | 2.13208351 |
| 108 | Chest pain (HP:0100749) | 2.11121722 |
| 109 | Bronchitis (HP:0012387) | 2.10357024 |
| 110 | Viral hepatitis (HP:0006562) | 2.09820965 |
| 111 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09586331 |
| 112 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09586331 |
| 113 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09586331 |
| 114 | Leukopenia (HP:0001882) | 2.08980760 |
| 115 | Abnormality of complement system (HP:0005339) | 2.08542974 |
| 116 | Vacuolated lymphocytes (HP:0001922) | 2.07110665 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05936440 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 2.05936440 |
| 119 | Urticaria (HP:0001025) | 2.03889382 |
| 120 | Slow saccadic eye movements (HP:0000514) | 2.03216724 |
| 121 | Acute hepatic failure (HP:0006554) | 1.99490348 |
| 122 | Arterial tortuosity (HP:0005116) | 1.99081480 |
| 123 | Increased density of long bones (HP:0006392) | 1.98960065 |
| 124 | Arthralgia (HP:0002829) | 1.98779685 |
| 125 | Hepatosplenomegaly (HP:0001433) | 1.98581970 |
| 126 | Abnormality of T cells (HP:0002843) | 1.97113858 |
| 127 | Lymphoma (HP:0002665) | 1.95470673 |
| 128 | Nephritis (HP:0000123) | 1.95131624 |
| 129 | Eosinophilia (HP:0001880) | 1.94113347 |
| 130 | Thrombocytosis (HP:0001894) | 1.93750614 |
| 131 | Glomerulopathy (HP:0100820) | 1.93639017 |
| 132 | Axonal loss (HP:0003447) | 1.93398251 |
| 133 | Purpura (HP:0000979) | 1.91064470 |
| 134 | Premature loss of primary teeth (HP:0006323) | 1.88404173 |
| 135 | Keratitis (HP:0000491) | 1.87285846 |
| 136 | Hypermelanotic macule (HP:0001034) | 1.85898560 |
| 137 | Amyloidosis (HP:0011034) | 1.82845179 |
| 138 | Abnormality of the pericardium (HP:0001697) | 1.81197794 |
| 139 | Abnormal platelet volume (HP:0011876) | 1.80973902 |
| 140 | Metaphyseal cupping (HP:0003021) | 1.76866642 |
| 141 | Difficulty running (HP:0009046) | 1.74932135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.48576289 |
| 2 | ERN1 | 3.32912626 |
| 3 | CSF1R | 3.16533882 |
| 4 | TYK2 | 3.13464384 |
| 5 | BLK | 2.92418903 |
| 6 | TGFBR2 | 2.86590755 |
| 7 | RIPK4 | 2.65367872 |
| 8 | MAP3K14 | 2.62402772 |
| 9 | PRPF4B | 2.56099373 |
| 10 | TBK1 | 2.46942366 |
| 11 | JAK1 | 2.33779351 |
| 12 | MAP3K10 | 2.28791285 |
| 13 | STK10 | 2.21663637 |
| 14 | GRK6 | 2.11443144 |
| 15 | MAP3K13 | 2.10161795 |
| 16 | SYK | 1.97468801 |
| 17 | IRAK4 | 1.96443045 |
| 18 | IRAK3 | 1.94308460 |
| 19 | CDK12 | 1.88820912 |
| 20 | BTK | 1.84649196 |
| 21 | KIT | 1.83201229 |
| 22 | SIK2 | 1.79792457 |
| 23 | IKBKB | 1.79130196 |
| 24 | EPHB1 | 1.73531556 |
| 25 | CSK | 1.64434119 |
| 26 | HCK | 1.63058656 |
| 27 | JAK3 | 1.56296454 |
| 28 | IKBKE | 1.53810321 |
| 29 | MAP3K11 | 1.53788584 |
| 30 | LRRK2 | 1.49192598 |
| 31 | SMG1 | 1.49048307 |
| 32 | FES | 1.45409228 |
| 33 | MAP3K3 | 1.44235713 |
| 34 | CAMK1D | 1.42928700 |
| 35 | EEF2K | 1.40478594 |
| 36 | CLK1 | 1.34455333 |
| 37 | ZAP70 | 1.29067369 |
| 38 | LYN | 1.26834938 |
| 39 | CAMK1G | 1.25685557 |
| 40 | MARK3 | 1.20746713 |
| 41 | CHUK | 1.18585356 |
| 42 | MAP3K1 | 1.12658528 |
| 43 | MARK2 | 1.12637279 |
| 44 | MATK | 1.08375551 |
| 45 | PIM1 | 1.07205619 |
| 46 | ITK | 1.04031959 |
| 47 | LCK | 1.03020617 |
| 48 | FGR | 1.00638035 |
| 49 | SIK3 | 1.00176162 |
| 50 | TRIB3 | 0.96447900 |
| 51 | YES1 | 0.94753626 |
| 52 | FGFR4 | 0.93030397 |
| 53 | FGFR3 | 0.89567944 |
| 54 | IRAK2 | 0.89407084 |
| 55 | JAK2 | 0.88343509 |
| 56 | TAOK2 | 0.88203208 |
| 57 | PTK6 | 0.86068182 |
| 58 | TESK2 | 0.84278748 |
| 59 | IRAK1 | 0.81735201 |
| 60 | TAOK3 | 0.81557399 |
| 61 | ALK | 0.81044083 |
| 62 | RPS6KA4 | 0.80262205 |
| 63 | MAPK15 | 0.79494160 |
| 64 | CDK19 | 0.78530829 |
| 65 | MAP2K3 | 0.75263244 |
| 66 | BMPR2 | 0.73412160 |
| 67 | MAP3K9 | 0.71648355 |
| 68 | TEC | 0.70947061 |
| 69 | SIK1 | 0.66056993 |
| 70 | GRK7 | 0.65298966 |
| 71 | BRD4 | 0.64993516 |
| 72 | EPHA3 | 0.63961500 |
| 73 | HIPK2 | 0.61822279 |
| 74 | MAPK12 | 0.60933308 |
| 75 | TNK2 | 0.59545340 |
| 76 | PKN2 | 0.59202518 |
| 77 | ABL1 | 0.57388061 |
| 78 | RAF1 | 0.56482233 |
| 79 | EGFR | 0.56440669 |
| 80 | PRKCQ | 0.55620047 |
| 81 | MAPK7 | 0.55608212 |
| 82 | PIK3CG | 0.54847617 |
| 83 | PDK1 | 0.53402286 |
| 84 | PAK4 | 0.53040025 |
| 85 | DYRK1B | 0.52380748 |
| 86 | BMX | 0.51543989 |
| 87 | MAPK11 | 0.48400509 |
| 88 | MST4 | 0.47652256 |
| 89 | TSSK6 | 0.45547468 |
| 90 | MAP3K6 | 0.44304450 |
| 91 | CDK9 | 0.44213552 |
| 92 | RPS6KL1 | 0.43220652 |
| 93 | RPS6KC1 | 0.43220652 |
| 94 | CDK6 | 0.41928624 |
| 95 | MAP2K4 | 0.41144236 |
| 96 | SGK3 | 0.41067332 |
| 97 | MAP3K8 | 0.40673933 |
| 98 | KSR2 | 0.40375680 |
| 99 | STK11 | 0.39431345 |
| 100 | CDC42BPA | 0.39298312 |
| 101 | INSR | 0.38859843 |
| 102 | MAPKAPK2 | 0.38837435 |
| 103 | NEK9 | 0.38313680 |
| 104 | MAP3K5 | 0.37945675 |
| 105 | CAMKK1 | 0.37247864 |
| 106 | PRKAA2 | 0.37030148 |
| 107 | RET | 0.36809956 |
| 108 | CDK4 | 0.36706781 |
| 109 | MAP2K6 | 0.36351994 |
| 110 | PKN1 | 0.36332900 |
| 111 | MAP3K2 | 0.36043081 |
| 112 | STK4 | 0.35633128 |
| 113 | RPS6KA6 | 0.35583086 |
| 114 | NLK | 0.35462426 |
| 115 | MAPK4 | 0.35269082 |
| 116 | SCYL2 | 0.34763929 |
| 117 | FYN | 0.34126690 |
| 118 | TAOK1 | 0.33396774 |
| 119 | PRKD2 | 0.33163805 |
| 120 | PRKD1 | 0.32932650 |
| 121 | PRKCH | 0.32438094 |
| 122 | GRK1 | 0.32172332 |
| 123 | PRKCD | 0.31868164 |
| 124 | TXK | 0.31337049 |
| 125 | PTK2B | 0.31042320 |
| 126 | STK38 | 0.30969825 |
| 127 | MAP3K7 | 0.29555529 |
| 128 | PRKCZ | 0.29519591 |
| 129 | PDPK1 | 0.28516244 |
| 130 | MELK | 0.28089394 |
| 131 | TTN | 0.27827686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.20776858 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.01217035 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.97176376 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89927561 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.62721762 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.51209684 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35569065 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.25004169 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.23905336 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15766882 |
| 11 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.15412579 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01264390 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.92422922 |
| 14 | * Tuberculosis_Homo sapiens_hsa05152 | 1.81489775 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77476075 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.75936220 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.75360158 |
| 18 | * Measles_Homo sapiens_hsa05162 | 1.73616050 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.67814144 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63221071 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62972983 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.62464021 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58499339 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53440968 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.52020356 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51476100 |
| 27 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46578434 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45748231 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44730487 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40157503 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35508939 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.34859109 |
| 33 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.34166540 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.33912788 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.33366323 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30683711 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.30582190 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27776130 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24566114 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22319242 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15741800 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15043337 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08695295 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.08127200 |
| 45 | * Malaria_Homo sapiens_hsa05144 | 1.06872741 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03756175 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.02251277 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.99618075 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99458094 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98656405 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.98620612 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93667363 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93122026 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89299171 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88799513 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88306729 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87614157 |
| 58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87304935 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83004467 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81289728 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77369798 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75458122 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73784287 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73747278 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72037287 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.71791778 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70559074 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68707839 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68527039 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68402481 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66767895 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65461339 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64750808 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64321723 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61925954 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59634844 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.59081458 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58983058 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58793582 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.58350660 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.58020519 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57963965 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57418090 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.56183664 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55325741 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54881734 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53832339 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51982449 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.50955143 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50950713 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50846649 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50323758 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49222972 |
| 94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48443454 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47863224 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.47761645 |
| 97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46956891 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46473188 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46170913 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45069741 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44862788 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44345283 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42352159 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40255963 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39660317 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39186186 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37767020 |
| 108 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.37140372 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36416733 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36357996 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.34438677 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.34267785 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33601979 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.32835676 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.31560236 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.31418159 |

